A standard lipid panel is one of the most commonly ordered blood tests in primary care. It gives you four numbers: total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides. Most lab reports display these alongside reference ranges marked “normal” or “high.” But the relationship between these values and cardiovascular risk is considerably more nuanced than those flags suggest.
LDL: the one everyone worries about
LDL (low-density lipoprotein) is often called “bad cholesterol,” though this label is an oversimplification. LDL particles transport cholesterol from the liver to cells throughout the body. Problems arise when LDL particles become oxidized and infiltrate arterial walls, contributing to plaque formation (atherosclerosis).
The standard LDL measurement on most panels is actually a calculated estimate (using the Friedewald equation), not a direct measurement. For people with high triglycerides or very low LDL, this estimate can be inaccurate. Direct LDL measurement or particle count (LDL-P) may give a clearer picture of actual risk.
HDL: not just “good cholesterol”
HDL (high-density lipoprotein) particles transport cholesterol from the arteries back to the liver for removal — a process called reverse cholesterol transport. Higher HDL is generally associated with lower cardiovascular risk, but the relationship is not linear and HDL alone is a poor predictor of events. Several clinical trials attempting to raise HDL pharmacologically found no reduction in cardiovascular outcomes, suggesting HDL quantity and HDL function are separate matters.
Triglycerides and the full picture
Triglycerides are the storage form of fat in the body. Elevated triglycerides, particularly in combination with low HDL and high non-HDL cholesterol, are associated with insulin resistance and metabolic syndrome. This pattern — often called atherogenic dyslipidemia — may be more predictive of cardiovascular risk than LDL alone in some populations.
What your panel does not tell you
A standard lipid panel does not tell you about LDL particle size and number (small, dense LDL particles are more atherogenic than large fluffy ones), lipoprotein(a) — a genetically determined particle that strongly predicts cardiovascular risk, inflammation markers like hsCRP, or your overall cardiovascular risk trajectory over time. Context matters enormously: the same LDL value carries very different risk implications for a 35-year-old non-smoker versus a 60-year-old with diabetes and hypertension.
Reading your results with Vogelview
When you upload a lipid panel to Vogelview, we interpret each biomarker against age- and sex-appropriate reference ranges, flag patterns (like the triglyceride/HDL ratio) that may be more informative than individual values, and note where your genetic variants may influence your lipid metabolism — for example, variants in PCSK9, APOE, and LDLR that can substantially affect LDL levels independent of diet.